Want to join the conversation?
$ZUMZ's 3Q16 gross margin is expected to fall 75-125 BPs versus 3Q15, due mainly to deleveraging of store occupancy costs. Consolidated operating margins are expected to be 4-5%. For 2016, the company expects product margins to improve from 2015, with the largest YoverY opportunity in 4Q16. $ZUMZ plans SG&A to grow at a greater rate than in 2015.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?